查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751021

2025年全球人類原代細胞培養市場報告

Human Primary Cell Culture Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，人類原代細胞培養市場規模將快速成長。 2029年，該市場規模將成長至58.2億美元，複合年成長率為11.3%。預測期內的成長歸因於再生醫學投資的增加、精準醫療應用的不斷成長、政府對細胞研究的資助增加、政府支持力度的加強以及人類原代細胞培養在毒理學檢測中的應用日益增多。預測期內的主要趨勢包括：人工智慧 (AI) 在細胞培養分析中的整合、無血清和化學成分確定培養基的開發、細胞培養過程自動化程度的提高、器官晶片技術的興起以及免疫療法研究中對原代細胞日益成長的需求。

人們對細胞和基因療法日益成長的關注預計將推動人類原代細胞培養市場的擴張。細胞和基因療法是一種尖端治療方法透過修改和替換遺傳物質和細胞來解決疾病的分子根源。這種日益成長的興趣背後的原因是人們希望它能夠透過針對遺傳疾病、罕見疾病和癌症的根本原因來提供持久甚至根治性的解決方案。人類原代細胞培養在開發這些治療方法、製造病毒載體和測試基因編輯方法中起著關鍵作用。例如，2024 年 7 月，美國非營利組織美國基因和細胞治療學會 (ASGCT) 報告稱，第二季度美國啟動了 76 項基因療法臨床試驗。因此，人們對細胞和基因療法日益成長的關注正在加速人類原代細胞培養市場的成長。

iPSC 和 ESC 技術將成體細胞和胚胎細胞重編程為多功能狀態，使其能夠分化為各種細胞類型，用於科學研究、治療開發和疾病建模。例如，2024 年 7 月，印度生命科學和生物技術公司 BioServe Biotechnologies India Pvt Ltd. 推出了 REPROCELL 的先進幹細胞產品線，以支持印度的研究和藥物研發。這些產品包括專用細胞培養基、幹細胞分化套件、3D 培養系統、藥物研發工具等，透過 iPSC 和 ESC 創新促進再生醫學和臨床前研究。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人類原代細胞培養PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球人類原代細胞培養市場：成長率分析
  • 全球人類原代細胞培養市場表現：規模與成長，2019-2024
  • 全球人類原代細胞培養市場預測：規模與成長，2024-2029，2034年
  • 全球人類原代細胞培養總目標市場（TAM）

第6章市場區隔

  • 全球人類原代細胞培養市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 初代細胞
  • 試劑和補充劑
  • 裝置
  • 初代細胞培養基
  • 其他耗材
  • 全球人類原代細胞培養市場：應用、效能及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物研發
  • 開發治療方法
  • 再生醫學
  • 其他用途
  • 全球人類原代細胞培養市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 合約研究組織（CRO）
  • 學術研究所
  • 全球人類原代細胞培養市場細分（初代細胞類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 人類真皮纖維母細胞（HDF）
  • 人類表皮角質細胞（HEK）
  • 間質幹細胞（HMSC）
  • 人類內皮細胞
  • 人類造血細胞
  • 全球人類原代細胞培養市場試劑和補充劑細分（按類型、實際和預測），2019-2024 年、2024-2029 年、2034 年
  • 生長因子和細胞激素
  • 抗生素和抗真菌藥物
  • 牛（FBS）
  • 緩衝液和化學品
  • 冷凍保存試劑
  • 全球人類原代細胞培養市場，按儀器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 細胞培養箱
  • 生物安全櫃
  • 離心機
  • 細胞計數器和分析儀
  • 顯微鏡
  • 全球人類原代細胞培養市場細分（初代細胞培養基類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 無血清培養基
  • 化學成分確定的培養基
  • 古典媒體
  • 無蛋白培養基
  • 客製化媒體
  • 全球人類原代細胞培養市場其他耗材細分市場（按類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 培養皿和培養板
  • 燒瓶和瓶子
  • 移液管和吸頭
  • 細胞過濾器和濾膜
  • 塗層培養表面

第7章 區域和國家分析

  • 全球人類原代細胞培養市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球人類原代細胞培養市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 人類原代細胞培養市場：競爭格局
  • 人類原代細胞培養市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • American Type Culture Collection Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • PromoCell GmbH
  • Krishgen Biosystems Private Limited
  • Cell Culture Company Limited Liability Company
  • HiMedia Laboratories Private Limited
  • 3H Biomedical Aktiebolag
  • ScienCell Research Laboratories Inc.
  • Cell Applications Incorporated
  • Life Technologies Private Limited
  • PELOBIOTECH Gesellschaft mit beschrankter Haftung
  • Amsbio Limited
  • AcceGen Biotechnology Limited Liability Company
  • Cell Biologics Incorporated
  • BI Biotech India Private Limited
  • Innoprot Sociedad Limitada
  • ZenBio Incorporated

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年人類原代細胞培養市場：提供新機會的國家
  • 2029年人類原代細胞培養市場：細分領域帶來新機會
  • 2029年人類原代細胞培養市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34874

Human primary cell culture refers to the process of isolating cells directly from human tissues such as blood or bone marrow and maintaining them in a controlled environment for research or therapeutic use. These cultures offer a more accurate reflection of in vivo biological conditions compared to immortalized cell lines, making them highly valuable for scientific and medical applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types in human primary cell culture include primary cells, reagents and supplements, instruments, primary cell culture media, and other related products. Primary cells are directly extracted from living tissues and are commonly used in research, drug testing, and various medical studies. Applications of human primary cell culture span drug discovery, therapy development, regenerative medicine, and more. These products and technologies serve a diverse range of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutions.

The human primary cell culture market research report is one of a series of new reports from The Business Research Company that provides human primary cell culture market statistics, including human primary cell culture industry global market size, regional shares, competitors with a human primary cell culture market share, detailed human primary cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the human primary cell culture industry. This human primary cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human primary cell culture market size has grown rapidly in recent years. It will grow from $3.39 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to the increasing adoption of cell-based research, rising demand for personalized medicine, a growing emphasis on drug discovery, an enhanced focus on individualized treatment approaches, and the expanding applications of human primary cell culture in cancer research.

The human primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth during the forecast period can be attributed to rising investments in regenerative medicine, increased use in precision medicine, growing government funding for cell-based research, enhanced governmental support, and the expanding use of human primary cell culture in toxicology testing. Key trends anticipated in the forecast period include the integration of artificial intelligence (AI) in cell culture analysis, the development of serum-free and chemically defined media, increasing automation in cell culture processes, the emergence of organ-on-a-chip technology, and the growing demand for primary cells in immunotherapy research.

The rising emphasis on cell and gene therapies is anticipated to drive the expansion of the human primary cell culture market. Cell and gene therapies are cutting-edge treatments that involve modifying or replacing genetic material or cells to address diseases at their molecular roots. This growing interest is fueled by the promise of these therapies to offer long-lasting or even curative solutions for genetic disorders, rare diseases, and cancers by targeting their underlying causes. Human primary cell cultures play a vital role in developing these therapies, producing viral vectors, and testing gene-editing approaches. For example, in July 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based nonprofit organization, reported that 76 gene therapy trials were launched in the United States in Q2 2024 a 25% rise compared to the first quarter. As a result, the increasing focus on cell and gene therapies is accelerating the growth of the human primary cell culture market.

Leading companies in the human primary cell culture market are investing in the development of advanced technologies such as induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) to boost research capabilities, drug discovery, and regenerative medicine efforts. iPSC and ESC technologies involve reprogramming adult or embryonic cells into pluripotent states, enabling them to differentiate into various cell types for use in scientific research, therapy development, and disease modeling. For instance, in July 2024, BioServe Biotechnologies India Pvt Ltd., an India-based life sciences and biotechnology company, introduced a new range of advanced stem cell products from REPROCELL to support research and drug discovery in India. These offerings include specialized cell culture media, stem cell differentiation kits, 3D culture systems, and drug discovery tools advancing regenerative medicine and preclinical studies powered by iPSC and ESC innovations.

In April 2023, AnaBios Corporation, a US-based contract research organization (CRO), announced the acquisition of Cell Systems Corporation for an undisclosed sum. Through this acquisition, AnaBios seeks to broaden its portfolio of biologically relevant human tissues and primary cells, enhancing research capabilities in cell biology and drug discovery. Cell Systems Corporation, also based in the US, is a provider of human primary cells, specialized cell culture media, and related reagents.

Major players in the human primary cell culture market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Lonza Group AG, STEMCELL Technologies Inc., American Type Culture Collection, PromoCell GmbH, Krishgen Biosystems Private Limited, Cell Culture Company Limited Liability Company, HiMedia Laboratories Private Limited, 3H Biomedical Aktiebolag, ScienCell Research Laboratories Inc., Cell Applications Incorporated, Life Technologies Private Limited, PELOBIOTECH Gesellschaft mit beschrankter Haftung, Amsbio Limited, AcceGen Biotechnology Limited Liability Company, Cell Biologics Incorporated, BI Biotech India Private Limited, Innoprot Sociedad Limitada, ZenBio Incorporated, Evercyte GmbH, Cell Systems Corporation, Cytion GmbH, Kosheeka Private Limited.

North America was the largest region in the human primary cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human primary cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human primary cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human primary cell culture market consists of revenues earned by entities by providing services such as cell isolation, culture media development, cryopreservation, cell characterization, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The human primary cell culture market also includes sales of culture media, reagents, bioreactors, incubators, cell storage systems, and imaging systems used in regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Primary Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human primary cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human primary cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human primary cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Primary Cells; Reagents And Supplements; Instruments; Primary Cell Culture Media; Other Consumables
  • 2) By Applications: Drug Discovery; Therapy Development; Regenerative Medicine; Other Applications
  • 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Academic And Research Institutions
  • Subsegments:
  • 1) By Primary Cells: Human Dermal Fibroblasts (HDF); Human Epidermal Keratinocytes (HEK); Human Mesenchymal Stem Cells (HMSC); Human Endothelial Cells; Human Hematopoietic Cells
  • 2) By Reagents And Supplements: Growth Factors And Cytokines; Antibiotics And Antimycotics; Fetal Bovine Serum (FBS); Buffers And Chemicals; Cryopreservation Reagents
  • 3) By Instruments: Cell Culture Incubators; Biosafety Cabinets; Centrifuges; Cell Counters And Analyzers; Microscopes
  • 4) By Primary Cell Culture Media: Serum-Free Media; Chemically Defined Media; Classical Media; Protein-Free Media; Custom Media
  • 5) By Other Consumables: Culture Dishes And Plates; Flasks And Bottles; Pipettes And Tips; Cell Strainers And Filters; Coated Culture Surfaces
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck & Co. Inc.; Lonza Group AG; STEMCELL Technologies Inc.; American Type Culture Collection
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Primary Cell Culture Market Characteristics

3. Human Primary Cell Culture Market Trends And Strategies

4. Human Primary Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Primary Cell Culture Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Human Primary Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Human Primary Cell Culture Market Growth Rate Analysis
  • 5.4. Global Human Primary Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Human Primary Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Human Primary Cell Culture Total Addressable Market (TAM)

6. Human Primary Cell Culture Market Segmentation

  • 6.1. Global Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Cells
  • Reagents And Supplements
  • Instruments
  • Primary Cell Culture Media
  • Other Consumables
  • 6.2. Global Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery
  • Therapy Development
  • Regenerative Medicine
  • Other Applications
  • 6.3. Global Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic And Research Institutions
  • 6.4. Global Human Primary Cell Culture Market, Sub-Segmentation Of Primary Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Dermal Fibroblasts (HDF)
  • Human Epidermal Keratinocytes (HEK)
  • Human Mesenchymal Stem Cells (HMSC)
  • Human Endothelial Cells
  • Human Hematopoietic Cells
  • 6.5. Global Human Primary Cell Culture Market, Sub-Segmentation Of Reagents And Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Growth Factors And Cytokines
  • Antibiotics And Antimycotics
  • Fetal Bovine Serum (FBS)
  • Buffers And Chemicals
  • Cryopreservation Reagents
  • 6.6. Global Human Primary Cell Culture Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture Incubators
  • Biosafety Cabinets
  • Centrifuges
  • Cell Counters And Analyzers
  • Microscopes
  • 6.7. Global Human Primary Cell Culture Market, Sub-Segmentation Of Primary Cell Culture Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum-Free Media
  • Chemically Defined Media
  • Classical Media
  • Protein-Free Media
  • Custom Media
  • 6.8. Global Human Primary Cell Culture Market, Sub-Segmentation Of Other Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture Dishes And Plates
  • Flasks And Bottles
  • Pipettes And Tips
  • Cell Strainers And Filters
  • Coated Culture Surfaces

7. Human Primary Cell Culture Market Regional And Country Analysis

  • 7.1. Global Human Primary Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Human Primary Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Primary Cell Culture Market

  • 8.1. Asia-Pacific Human Primary Cell Culture Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Primary Cell Culture Market

  • 9.1. China Human Primary Cell Culture Market Overview
  • 9.2. China Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Primary Cell Culture Market

  • 10.1. India Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Primary Cell Culture Market

  • 11.1. Japan Human Primary Cell Culture Market Overview
  • 11.2. Japan Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Primary Cell Culture Market

  • 12.1. Australia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Primary Cell Culture Market

  • 13.1. Indonesia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Primary Cell Culture Market

  • 14.1. South Korea Human Primary Cell Culture Market Overview
  • 14.2. South Korea Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Primary Cell Culture Market

  • 15.1. Western Europe Human Primary Cell Culture Market Overview
  • 15.2. Western Europe Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Primary Cell Culture Market

  • 16.1. UK Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Primary Cell Culture Market

  • 17.1. Germany Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Primary Cell Culture Market

  • 18.1. France Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Primary Cell Culture Market

  • 19.1. Italy Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Primary Cell Culture Market

  • 20.1. Spain Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Primary Cell Culture Market

  • 21.1. Eastern Europe Human Primary Cell Culture Market Overview
  • 21.2. Eastern Europe Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Primary Cell Culture Market

  • 22.1. Russia Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Primary Cell Culture Market

  • 23.1. North America Human Primary Cell Culture Market Overview
  • 23.2. North America Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Primary Cell Culture Market

  • 24.1. USA Human Primary Cell Culture Market Overview
  • 24.2. USA Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Primary Cell Culture Market

  • 25.1. Canada Human Primary Cell Culture Market Overview
  • 25.2. Canada Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Primary Cell Culture Market

  • 26.1. South America Human Primary Cell Culture Market Overview
  • 26.2. South America Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Primary Cell Culture Market

  • 27.1. Brazil Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Primary Cell Culture Market

  • 28.1. Middle East Human Primary Cell Culture Market Overview
  • 28.2. Middle East Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Primary Cell Culture Market

  • 29.1. Africa Human Primary Cell Culture Market Overview
  • 29.2. Africa Human Primary Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Human Primary Cell Culture Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Human Primary Cell Culture Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Primary Cell Culture Market Competitive Landscape And Company Profiles

  • 30.1. Human Primary Cell Culture Market Competitive Landscape
  • 30.2. Human Primary Cell Culture Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. American Type Culture Collection Overview, Products and Services, Strategy and Financial Analysis

31. Human Primary Cell Culture Market Other Major And Innovative Companies

  • 31.1. PromoCell GmbH
  • 31.2. Krishgen Biosystems Private Limited
  • 31.3. Cell Culture Company Limited Liability Company
  • 31.4. HiMedia Laboratories Private Limited
  • 31.5. 3H Biomedical Aktiebolag
  • 31.6. ScienCell Research Laboratories Inc.
  • 31.7. Cell Applications Incorporated
  • 31.8. Life Technologies Private Limited
  • 31.9. PELOBIOTECH Gesellschaft mit beschrankter Haftung
  • 31.10. Amsbio Limited
  • 31.11. AcceGen Biotechnology Limited Liability Company
  • 31.12. Cell Biologics Incorporated
  • 31.13. BI Biotech India Private Limited
  • 31.14. Innoprot Sociedad Limitada
  • 31.15. ZenBio Incorporated

32. Global Human Primary Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Primary Cell Culture Market

34. Recent Developments In The Human Primary Cell Culture Market

35. Human Primary Cell Culture Market High Potential Countries, Segments and Strategies

  • 35.1 Human Primary Cell Culture Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Human Primary Cell Culture Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Human Primary Cell Culture Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34874_Human_Primary_Cell_Culture_GMR_2025